Why 🐵 UnitedStatesNews-NoOpEd picked: ​FTC and seven states seek contempt ruling against Shkreli over pharma ban

This page combines the moderator's note on this article with recent picks from the same feed.

Source: theguardian.com

<p>Martin Shkreli’s 2022 release conditions bar him from participating in the pharmaceutical industry, including ownership stakes or business decisions</p><p>The Federal Trade Commission (FTC) and seven US states have alleged that pharmaceutical executive Martin Shkreli repeatedly violated a <a href="https://www.theguardian.com/us-news/2022/jan/14/martin-shkreli-barred-drug-industry-fined-us-court" rel="nofollow noopener noreferrer ugc" target="_blank">lifetime ban</a> on participating in the pharmaceutical industry, and they are asking a judge to hold him in contempt.</p><p>In a <a href="https://www.ftc.gov/news-events/news/press-releases/2026/10/ftc-states-ask-federal-court-hold-martin-shkreli-contempt-allegedly-violating-lifetime" rel="nofollow noopener noreferrer ugc" target="_blank">motion </a>filed on Tuesday in US district court in New York City, the FTC and its state co-plaintiffs allege that 43-year-old Shkreli – nicknamed the “Pharma Bro” – has traded stocks in at least 60 pharmaceutical companies and publicly commented on their businesses since his release from prison in May 2022.</p> <a href="https://www.theguardian.com/us-news/2026/oct/13/martin-shkreli-ftc-ruling-pharma-ban" rel="nofollow noopener noreferrer ugc" target="_blank">Continue reading...</a>

Topics: TOP_STORIES, GENERAL_NEWS, BUSINESS, POLITICS, US